KM Financial Solutions | Private equity firm EQT increases offer for Sweden’s Karo Pharma
41910
post-template-default,single,single-post,postid-41910,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Private equity firm EQT increases offer for Sweden’s Karo Pharma

Private equity firm EQT increases offer for Sweden’s Karo Pharma

Private equity firm EQT on
Wednesday bumped up its offer for Swedish specialty pharma group
Karo Pharma to 6.15 billion Swedish crowns ($694
million), citing in part stock market performance since its
original offer two months ago.

No Comments

Sorry, the comment form is closed at this time.